Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 4
2019 3
2020 4
2021 2
2022 2
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Iris melanoma: Prognostication for metastasis.
Melendez-Moreno A, Yeşiltaş YS, Wrenn J, Singh AD. Melendez-Moreno A, et al. Among authors: yesiltas ys. Surv Ophthalmol. 2023 Sep-Oct;68(5):957-963. doi: 10.1016/j.survophthal.2023.05.006. Epub 2023 May 18. Surv Ophthalmol. 2023. PMID: 37207703 Review.
Radiation Optic Neuropathy: Management Options.
Oakey Z, Yeşiltaş YS, Singh AD. Oakey Z, et al. Among authors: yesiltas ys. Ocul Oncol Pathol. 2023 Dec;9(5-6):166-171. doi: 10.1159/000533426. Epub 2023 Aug 7. Ocul Oncol Pathol. 2023. PMID: 38089180 Free PMC article. Review.
Uveal melanoma in African Americans: Diagnostic challenges.
Yeşiltaş YS, Oakey Z, Wrenn J, Yeaney G, Brainard J, Lorek B, Singh AD. Yeşiltaş YS, et al. Surv Ophthalmol. 2024 Mar-Apr;69(2):190-197. doi: 10.1016/j.survophthal.2023.06.011. Epub 2023 Jul 3. Surv Ophthalmol. 2024. PMID: 37406779 Review.
Overview of benign and malignant lacrimal gland tumors.
Gündüz AK, Yeşiltaş YS, Shields CL. Gündüz AK, et al. Among authors: yesiltas ys. Curr Opin Ophthalmol. 2018 Sep;29(5):458-468. doi: 10.1097/ICU.0000000000000515. Curr Opin Ophthalmol. 2018. PMID: 30028745 Review.
Iris freckle: a distinct entity.
Yeşiltaş YS, Zhou M, Zabor EC, Oakey Z, Singh N, Sedaghat A, Yeaney G, Singh AD. Yeşiltaş YS, et al. Br J Ophthalmol. 2024 May 27:bjo-2023-325009. doi: 10.1136/bjo-2023-325009. Online ahead of print. Br J Ophthalmol. 2024. PMID: 38802168
21 results